150 related articles for article (PubMed ID: 37175616)
1. Ultrastructural and Molecular Investigation on Peripheral Leukocytes in Alzheimer's Disease Patients.
Giannelli R; Canale P; Del Carratore R; Falleni A; Bernardeschi M; Forini F; Biagi E; Curzio O; Bongioanni P
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175616
[TBL] [Abstract][Full Text] [Related]
2. Glial activation and inflammation along the Alzheimer's disease continuum.
Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
[TBL] [Abstract][Full Text] [Related]
3. Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
Drake JD; Chambers AB; Ott BR; Daiello LA;
J Alzheimers Dis; 2021; 80(4):1553-1565. PubMed ID: 33720880
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease: The role of T lymphocytes in neuroinflammation and neurodegeneration.
Asamu MO; Oladipo OO; Abayomi OA; Adebayo AA
Brain Res; 2023 Dec; 1821():148589. PubMed ID: 37734576
[TBL] [Abstract][Full Text] [Related]
5. Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia.
Xiang Z; Haroutunian V; Ho L; Purohit D; Pasinetti GM
Dis Markers; 2006; 22(1-2):95-102. PubMed ID: 16410654
[TBL] [Abstract][Full Text] [Related]
6. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
7. White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer's disease rat model.
Ivanova N; Liu Q; Agca C; Agca Y; Noble EG; Whitehead SN; Cechetto DF
J Neuroinflammation; 2020 Jan; 17(1):29. PubMed ID: 31964387
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.
Lueg G; Gross CC; Lohmann H; Johnen A; Kemmling A; Deppe M; Groger J; Minnerup J; Wiendl H; Meuth SG; Duning T
Neurobiol Aging; 2015 Jan; 36(1):81-9. PubMed ID: 25277040
[TBL] [Abstract][Full Text] [Related]
9. Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
van de Mortel LA; Thomas RM; van Wingen GA;
J Alzheimers Dis; 2021; 83(2):705-720. PubMed ID: 34366336
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
11. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
12. Relationship between proinflammatory cytokines (Il-1beta, Il-18) and leukocyte telomere length in mild cognitive impairment and Alzheimer's disease.
Scarabino D; Peconi M; Broggio E; Gambina G; Maggi E; Armeli F; Mantuano E; Morello M; Corbo RM; Businaro R
Exp Gerontol; 2020 Jul; 136():110945. PubMed ID: 32289486
[TBL] [Abstract][Full Text] [Related]
13. Platelet Total PLA
Balietti M; Casoli T; Giacconi R; Giuli C
Rejuvenation Res; 2022 Feb; 25(1):16-24. PubMed ID: 34913745
[TBL] [Abstract][Full Text] [Related]
14. Serum IL-6, sAXL, and YKL-40 as systemic correlates of reduced brain structure and function in Alzheimer's disease: results from the DELCODE study.
Brosseron F; Maass A; Kleineidam L; Ravichandran KA; Kolbe CC; Wolfsgruber S; Santarelli F; Häsler LM; McManus R; Ising C; Röske S; Peters O; Cosma NC; Schneider LS; Wang X; Priller J; Spruth EJ; Altenstein S; Schneider A; Fliessbach K; Wiltfang J; Schott BH; Buerger K; Janowitz D; Dichgans M; Perneczky R; Rauchmann BS; Teipel S; Kilimann I; Görß D; Laske C; Munk MH; Düzel E; Yakupow R; Dobisch L; Metzger CD; Glanz W; Ewers M; Dechent P; Haynes JD; Scheffler K; Roy N; Rostamzadeh A; Spottke A; Ramirez A; Mengel D; Synofzik M; Jucker M; Latz E; Jessen F; Wagner M; Heneka MT;
Alzheimers Res Ther; 2023 Jan; 15(1):13. PubMed ID: 36631909
[TBL] [Abstract][Full Text] [Related]
15. Mild cognitive impairment represents early-stage Alzheimer disease.
Morris JC; Storandt M; Miller JP; McKeel DW; Price JL; Rubin EH; Berg L
Arch Neurol; 2001 Mar; 58(3):397-405. PubMed ID: 11255443
[TBL] [Abstract][Full Text] [Related]
16. Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.
Da X; Toledo JB; Zee J; Wolk DA; Xie SX; Ou Y; Shacklett A; Parmpi P; Shaw L; Trojanowski JQ; Davatzikos C;
Neuroimage Clin; 2014; 4():164-73. PubMed ID: 24371799
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer's disease.
Casati M; Ferri E; Gussago C; Mazzola P; Abbate C; Bellelli G; Mari D; Cesari M; Arosio B
Eur J Neurol; 2018 Jun; 25(6):805-810. PubMed ID: 29377401
[TBL] [Abstract][Full Text] [Related]
18. Identification of Alzheimer's Disease and Mild Cognitive Impairment Using Networks Constructed Based on Multiple Morphological Brain Features.
Zheng W; Yao Z; Xie Y; Fan J; Hu B
Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Oct; 3(10):887-897. PubMed ID: 30077576
[TBL] [Abstract][Full Text] [Related]
19. Molecular Imaging of Neuroinflammation in Alzheimer's Disease and Mild Cognitive Impairment.
Kim J; Kim YK
Adv Exp Med Biol; 2023; 1411():301-326. PubMed ID: 36949316
[TBL] [Abstract][Full Text] [Related]
20. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
